Conditions: Mild and Moderate Renal Impairment
Keywords: Renal Impairment, LCZ696
Allocation: NA | Intervention model: SINGLE_GROUP
Enrollment: 32
Healthy volunteers: yes

Brief summary:
The purpose of this study is to determine the multiple dose pharmacokinetics of LCZ696 and its metabolites in subjects with mild to moderate renal impairment and to evaluate the safety of LCZ696 in this population.

Detailed description:

Arms:
arm 1: LCZ696 400 mg once daily for 5 days

Interventions: intervention 1: LCZ696
Intervention descriptions: intervention 1: LCZ696 400 mg once daily

Protocol document: